Update, November 2, 2026
Palantir (PLTR) fell 8.9% over the five sessions through November 2, closing at $181.07, as the broader tech sector (XLK -5.5%) and S&P 500 (SPY -1.3%) also declined. The stock dropped 1.7% on the day, ahead of earnings due after the close, with options traders showing elevated bearish sentiment per CNBC. The 5-day move underperformed the sector by 3.4 percentage points, extending a 50-day lag versus the S&P 500 (-1.6%) even as it still leads XLK (+4.3%).
The picture holds: the long-term uptrend (price above its 40-week average) remains intact, but the pullback has deepened. The stock is now below its 50-day SMA ($186.93), which has flipped from support to resistance. RSI at 29.5 is oversold, and the 5-day drop has taken price to the $175 round support. A daily close above $186.93 on above-average volume would signal a breakout attempt, with the 52-week high at $209.05 as the target (reward-to-risk 1.6, below the 3-to-1 threshold). What would change the picture: a weekly close below the 200-day SMA at $153.59. The prior invalidation level of $163.55 (swing zone) now sits between current price and that trend-ending level. Earnings are due today, and a negative reaction could test $163.55 or lower. The Guardian reported that 29 NHS hospital trusts listed as benefiting from Palantir's platform say they are not using it, adding to the bearish narrative ahead of results.
Palantir Technologies (PLTR) rose about 3% to $198.48 on October 21, 2026, recovering part of a 5% pullback from its record close of $209.05, though no company news clearly explains the jump. The weekly uptrend is intact and the stock is outpacing both the S&P 500 and the tech sector, so the balance of evidence leans positive with high conviction. The catch is the math: from $200, the nearest target is only $209.05, well short of 3 to 1.
Why it matters
The one clear catalyst this week came on Monday, October 19, when shares rose about 5.5% after a partnership with Knox Systems, a federal and Defense Department managed cloud provider, aimed at speeding customer acceptance under FedRAMP, as The Motley Fool reported. Since then the headlines have leaned the other way. ARK sold 27,790 shares on Tuesday, Investing.com reported, and a director sold 16,000 shares at prices between $193.41 and $200.66 under a trading plan set up in December 2025, so the timing was scheduled long before this week. Separately, the Financial Times reported that HSBC is reviewing whether to drop PLTR from a $9 billion Islamic index fund. None of this is an earnings event, and none explains today's 3.05% gain from Tuesday's $192.60 close.
Little of the good news is a surprise to the market. The stock closed at a record $209.05 on October 9, has gained about 8% in a month and about 36% in six months, and is now 5.1% below that peak. Over the last five days PLTR fell 1.2%, while the S&P 500 rose 0.15% and the technology sector ETF (XLK) fell 1.5%. The market was flat, the sector slipped, and PLTR moved with the sector, finishing 0.3 points ahead of it. The pullback was mostly a sector move, not a verdict on the company. For context, PLTR is up 11.7% this year, behind the S&P 500 at 13.0% and well behind XLK at 30.2%.
The argument over PLTR is about price, not performance. The bullish case, as Seeking Alpha puts it, is that AI is in production at PLTR while others are still piloting. It points to 93% revenue growth last quarter and argues that 115 times earnings and 53 times sales are justified by compounding growth. The cautious side is about what happens after a big run. Michael Burry argues the next phase may resemble the period after the March 2000 peak, when market leaders fell sharply. One Yahoo Finance author names $140 as the price at which he would buy. Another Seeking Alpha author moved to neutral on a fair value of $141.2, although that piece cites a share price near $128.5, far below today's.
The analyst spread shows how little agreement there is on value. Of 26 analysts, the consensus is buy and the mean price target is $206.43, about 3.8% above the current price, so there is little upside left to the average target. Individual targets run from $80 to $265. At a market value of about $477 billion, the stock is priced for growth continuing near its recent pace.
What the evidence says
On the long term, the thesis is intact. The price is above its 40-week average, the 50-day average at $183.83 sits well above the 200-day at $152.97, and the stock is up 85% from its 52-week low of $107.27. The stock is in a mature advance that is pausing just under its record high after a strong six months. It is not in a topping pattern, since no key support has failed. The lag behind XLK this year is a reminder that PLTR is not the only way the sector has been rewarded.
For the next 2 to 6 weeks, the balance of evidence leans positive, and conviction is high at 3 of 4 points. The daily trend runs with the weekly uptrend. PLTR leads the S&P 500 by 7.6% over 50 days and leads XLK by 9.4%. The point that is missing shows up in the breakout math below, where the reward is small against the risk. The strongest case against this reading is that the stock is still below $200 and 5% under its peak. Volume is 71.5% below its 20-day average, though the session is young. ARK is selling, and valuation leaves little room for disappointment, with the mean price target barely above the price. That argument is why conviction is not higher. It does not tip the balance, because the weekly trend, the 50-day average and the relative strength all remain intact, and none of the selling has pushed the price below any of them.
Levels that matter
The structure holds above $183.83, the 50-day average. A first crack would be a close below it, since the stock has trended above that line through the advance. Below it, the round $175 and then $163.55, the swing zone, come next. The trend ends below $163.55, with the 200-day average at $152.97 and the round $150 beneath that.
The breakout level is a daily close above $200, a round number, on volume above its 20-day average. From there the first target is $209.05, the 52-week high, with $225 as the next round-number resistance. A breakout would be wrong below $181.72, which is the 50-day average minus a quarter of the 14-day average true range of $8.46. That gives a reward-to-risk of 0.5 to 1, which does not reach the 3 to 1 that makes a breakout worth the risk. Only a target far beyond $225 would lift the math to 3 to 1, and no resistance on the current map sits that far out.
What would change the picture
A weekly close below $163.55, the swing zone, would change the picture, because it would end the trend structure. The non-price fact that could bring that about is the next earnings report. If revenue growth slowed sharply from last quarter's 93%, or if guidance disappointed, the high valuation would lose its justification and the bearish arguments above would carry more weight.
What to watch
- Earnings on November 2, 2026: the number that matters is year-over-year revenue growth against last quarter's 93%.
- Sector moves: XLK is down 3.8% over a month, and PLTR has tracked it. Burry's rotation argument and the political backlash against big tech, as The Guardian frames it, are the themes that could move the whole group before PLTR's own news.
- Valuation versus consensus: the mean price target of $206.43 is 3.8% above the price, inside a range of $80 to $265, so the average analyst sees limited upside from here.